Prostate cancer screening in Tyrol, Austria: experience and results. Eur Urol 1999;35:523-38.Horninger W, Reissigl A, Rogatsch H, et al. Prostate cancer screening in the Tyrol, Austria: experience and results. Eur J Cancer 2000;36:1322-35. http://dx.doi.org/10.1016/S0959-8049(00)...
Prostate cancer screening results differ in men taking cholesterol-lowering statin drugs compared with non-users, a study conducted at Tampere University in Finland finds. In statin users, screening did not increase the incidence of prostate cancer as it did in other men. The study found the clea...
They commented that:"The real impact and tragedy of prostate cancer screening is the doubling of the lifetime risk of a diagnosis of prostate cancer with little if any decrease in the risk of dying from this disease."In 1985, before PSA was used in the US, an American man's lifetime ...
Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years. Cancer. 2017;123(4):592-599.PubMedGoogle ScholarCrossref 8. Schröder FH, Hugosson J, Roobol MJ, et al; ERSPC Investigators. Screening and prostate cancer mortality: results of ...
Updated results of the European Randomized nudy of Screening for Prostate Cancer reveal that PSA screening significantly reduces mortality from prostate cancer, but does not affect all-cause mortality. A total of 182,160 men (50–74 years old) from eight European countries were randomly assigned ...
Marc A. Bjurlin, DO, discusses ongoing efforts to optimize prostate cancer screening. Marc A. Bjurlin, DO Optimal screening in prostate cancer remains a work in progress, notes Marc A. Bjurlin, DO, particularly with the utilization of active surveillance and prostate-specific antigen (PSA) ...
The long-term ramifications of screening 2. The relatively high probability of further evaluation and biopsy with positive results 3. Potentially difficult decisions that may arise about using treatments that are associated with considerable morbidity and uncertain benefits (at the time) if cancer is ...
Progrès dans les recherches sur le cancerIlic D. Screening for prostate cancer: reflecting on the quality of evidence from the ERSPC and PLCO studies. Recent Results Cancer Res. 2014; 202 :65–71.Ilic D. Screening for prostate cancer: reflecting on the quality of evidence from the ERSPC ...
Is screening—an important means of cancer control for many sites—a reasonable approach for prostate cancer control? The answer is not straightforward because prostate cancer is not one, but three diseases: a latent form which will cause no harm; a progressive form which will become symptomatic ...
Prostate Cancer Screening According to the National Cancer Institute (NCI), prostate cancer is the second leading cancer killer among men. An estimated one in six men will be diagnosed with prostate cancer in his lifetime, and more than 30,000 Americans die of the disease each year. As a ...